The Cambridge Enterprise Ventures team are responsible for venture investing University of Cambridge funds into University of Cambridge spin-outs. The team invest in opportunities across the breadth of University research including quantum, silicon, sustainability, AI, med tech and drug discovery.
Christine’s background is in Life Science investment with a focus on drug discovery. She has supported numerous University of Cambridge spin-outs, including Carrick, Pretzel, Transition Bio, Z-factor, PhoreMost, Qkine, Spirea and Pharmenable.
With a degree and D. Phil in Chemistry from the University of Oxford, prior to becoming an investor, Christine had roles managing licensing of University intellectual property and before that working for a biotechnology spin-out from the University of Cambridge.
